Method of preventing or treating thrombosis using kappa-caseinoglycopeptide as active ingredient
US5063203A · kind A · utility
6Cited by
2References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 1990 |
| Grant date | Nov 5, 1991 |
| Priority date | — |
| Expiry date | May 9, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of .kappa.-caseinoglycopeptide or CGP, in particular from cow's ewe's, goat's or human milk, for the manufacture of a composition, in particular a medicament, for the prevention and/or the treatment of thrombi. A medicament of this kind can advantageously be presented in lyophilised form intended for injection, after being dissolved in a compatible solvent, or in the form of nanoparticles enclosed in capsules. Application to the prevention and the treatment of thrombi.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.